title: Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity.
abstract: OBJECTIVE
  The Trp64-->Arg allele of the beta 3-adrenergic receptor gene was recently proposed to be associated with an earlier onset of non-insulin-dependent diabetes mellitus (NIDDM), features of insulin resistance and a tendency to gain weight. We investigated whether the Arg64 allele predisposes to severe obesity.
  
  
  METHODS
  A genetic association study of 254 subjects with morbid obesity [body-mass index (BMI) > or = 40; mean 42.8 +/- 7.0] and 151 lean healthy control subjects [BMI < or = 25; mean BMI 22.3 +/- 1.9].
  
  
  METHODS
  beta 3-adrenergic receptor genotyping was carried out with a solid-phase minisequencing technique. Serum lipids, glucose and insulin levels in the obese subjects were also determined.
  
  
  RESULTS
  The frequency of the Arg64 did not significantly differ in the morbidly obese patients (9.1%) and lean controls (8.9%), nor was there any statistically significant association between the mean BMI values and the beta 3-adrenergic receptor genotype. However, obese subjects carrying the Arg64 allele developed obesity more often before the age of 15 y than those without it (P < 0.05, adjusted for multiple comparisons). The frequency of the Arg64 allele was similar in nondiabetic and diabetic patients; the mean age at the onset of NIDDM did not differ according to the beta 3-adrenergic receptor genotype. There was no significant association between the receptor genotype and the level of the serum cholesterol, HDL-cholesterol, triglyceride, glucose or insulin, nor was this polymorphism associated with the behavioural or psychopathological characteristics of the morbidly obese subjects. Response to a 16 w treatment program including a very-low calorie diet (VLCD) regimen, dietary and exercise counseling, as well as behavioural modifications, did not differ according to the genotype.
  
  
  CONCLUSIONS
  Our data do not support a significant role for the codon 64 polymorphism of the beta 3-adrenergic receptor as a genetic marker of morbid obesity. Although there was an association between the Arg64 allele and an earlier onset of obesity in individuals subsequently developing morbid obesity, this allele was not associated with the actual BMI gained or response to weight-loss therapy on a hypocaloric diet.
authors.affiliation: Department of Medicine, University of Helsinki, Finland.
authors.forename: L
authors.initials: L
authors.lastname: Oksanen
authors.forename: P
authors.initials: P
authors.lastname: Mustajoki
authors.forename: J
authors.initials: J
authors.lastname: Kaprio
authors.forename: K
authors.initials: K
authors.lastname: Kainulainen
authors.forename: O
authors.initials: O
authors.lastname: Jänne
authors.forename: L
authors.initials: L
authors.lastname: Peltonen
authors.forename: K
authors.initials: K
authors.lastname: Kontula
mesh_terms: D000328:Adult; D017668:Age of Onset; D000368:Aged; D000483:Alleles; D015992:Body Mass Index; D004247:DNA / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005247:Feeding Behavior; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000150:complications / Q000235:genetics* / Q000628:therapy; D010352:Patient Dropouts; D011110:Polymorphism, Genetic; D011943:Receptors, Adrenergic, beta / Q000235:genetics*; D022702:Receptors, Adrenergic, beta-3; D015431:Weight Loss / Q000235:genetics
chemical_list: D011943:Receptors, Adrenergic, beta; D022702:Receptors, Adrenergic, beta-3; D004247:DNA